GlassScriptPhysician profile
Sharon Beth Schwartz
NPI 1932224649
$2,233.73
in general payments reported to CMS, 2019-2025
39 companies · $496 in 2025
The $496 reported for 2025 was more than what 92% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $267 · 2023: $709 · 2024: $510 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,626 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.52 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $346.55 | 2022-2025 | Tezspire, Fasenra |
| Abbvie INC. | $203.60 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $161.05 | 2021-2024 | |
| Vertex Pharmaceuticals Incorporated | $140.14 | 2021-2025 | Trikafta |
| Baxter Healthcare | $120.44 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Volara System |
| Regeneron Healthcare Solutions, INC. | $115.29 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $103.61 | 2021-2023 | Nucala |
| Dexcom, INC. | $97.36 | 2021-2024 | Dexcom G6 Transmitter |
| Harmony Biosciences LLC | $81.89 | 2022-2025 | |
| Amgen INC. | $80.34 | 2022-2025 | Tezspire |
| Alexion Pharmaceuticals, INC. | $61.72 | 2021-2024 | Strensiq |
| Biomarin Pharmaceutical INC. | $59.79 | 2023-2024 | |
| Viatris Specialty LLC | $58.72 | 2025 | Tobi Podhaler |
| Genentech USA, INC. | $47.85 | 2023-2024 | Actemra |
| Electromed, INC. | $38.78 | 2023-2025 | Smartvest |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $38.05 | 2021 | |
| Chiesi USA, INC. | $35.53 | 2022-2023 | Bronchitol, Pertzye |
| Tolmar, INC. | $32.12 | 2023-2025 | Fensolvi |
| Kyowa Kirin, INC. | $31.06 | 2024-2025 | Crysvita |
| Xeris Pharmaceuticals, INC. | $29.66 | 2023 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $29.56 | 2024 | Eohilia, Gattex |
| Genzyme Corporation | $29.27 | 2023 | |
| Lilly USA, LLC | $28.46 | 2021-2023 | Baqsimi |
| Aimmune Therapeutics, INC. | $28.41 | 2024-2025 | Zenpep |
| Tandem Diabetes Care, INC. | $25.60 | 2022 | |
| Philips North America LLC | $19.96 | 2022 | |
| Sobi, INC | $16.92 | 2025 | |
| Insulet Corporation | $16.39 | 2023 | Omnipod |
| Sandoz INC. | $15.62 | 2023 | Hyrimoz |
| Amphastar Pharmaceuticals, INC. | $15.46 | 2024 | |
| Travere Therapeutics, INC. | $15.38 | 2022 | |
| Mylan Institutional INC. | $15.00 | 2023 | Hulio |
| Endo USA, INC. | $14.38 | 2024 | Supprelin |
| Ibsa Pharma INC. | $14.24 | 2023 | Tirosint, Licart |
| Endo Pharmaceuticals INC. | $14.05 | 2023 | Supprelin |
| Rhythm Pharmaceuticals, INC. | $14.04 | 2025 | Imcivree |
| Albireo Pharma, INC. | $13.06 | 2023 | Bylvay |
| Nestle Healthcare Nutrition INC. | $12.75 | 2023 | |
| Advanced Respiratory, INC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.